Scrip Symbol
RBLBANK (NSE)
RBL Bank Limited has made a regulatory disclosure regarding employee stock option grants approved by the Nomination and Remuneration Committee.
Key Quantitative Figures
- Total stock options granted: 16,66,130
- Equivalent equity shares: 16,66,130 shares of ₹10 each
- Exercise price per option: ₹372.80
- Vesting schedule: 30% after first year, 30% after second year, 40% after third year
- Exercise period: Five years from date of vesting
Pricing Mechanism
The exercise price of ₹372.80 per option is based on the latest available closing price on the previous trading day prior to the Grant Date on the stock exchange which recorded the higher trading volume, which was the National Stock Exchange of India Limited.
Regulatory Framework
The options were granted under:
- Employee Stock Option Plan 2013 (ESOP 2013)
- Employee Stock Option Plan 2018 (ESOP 2018)
Both plans were formulated based on SEBI (Share Based Employee Benefits and Sweat Equity) Regulations and have been amended to align with the requirements of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Additional Compliance
In compliance with Regulation 46(2) of the SEBI Listing Regulations, this information is being hosted on the Bank's website at www.rbl.bank.in.
Capital Structure Impact
The grant represents potential future equity dilution of 16,66,130 shares, though the disclosure does not provide current share capital figures to calculate the exact dilution percentage.
Financial Impact
The financial impact of the ESOP grant will be accounted for as per applicable accounting standards, though specific quantification of the expense is not provided in this disclosure.